---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-262152"
form_type: "8-K"
ticker: "IOBTQ"
cik: "0001865494"
company_name: "IO Biotech, Inc."
filed_at: "2022-10-13T23:59:59+00:00"
generated_at: "2026-06-23T03:55:35.125106+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# IO Biotech appoints Amy Sullivan as CFO effective Oct 15, 2022

## Summary
- Amy Sullivan, 53, appointed CFO and Principal Financial Officer, effective October 15, 2022.
- Annual base salary of $425,000 and target bonus of 45% of base salary.
- Granted option for 288,152 shares; vests 25% at 1 year, then monthly over 3 years.
- Ms. Sullivan previously served as CFO at TABA and chief strategy officer at Kiadis Pharma, leading its sale to Sanofi.
- She brings 25+ years of life sciences finance and corporate strategy experience.

## SEC filing metadata
- accession: 0001193125-22-262152
- form_type: 8-K
- ticker: IOBTQ
- cik: 0001865494
- company_name: IO Biotech, Inc.
- filed_at: 2022-10-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1865494/000119312522262152/0001193125-22-262152-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1865494/000119312522262152/d412480d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-262152
- JSON: https://secwatch.observer/filing/0001193125-22-262152.json
- Plain text: https://secwatch.observer/filing/0001193125-22-262152.txt

## Key facts
- Executive change
  Amy Sullivan was appointed as Chief Financial Officer at IO Biotech, Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On October 13, 2022, IO Biotech, Inc. (the “Company”) appointed Amy Sullivan, 53, as the Company’s Chief Financial Officer, effective as of October 15, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1865494/000119312522262152/0001193125-22-262152-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.